Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EIF2C2 |
| Upstream (Parents) |
|---|
| (<<) TNFRSF21 → EIF2C2 |
| (<<) E2F5 → EIF2C2 |
| (<<) YWHAZ → EIF2C2 |
| (<<) FZD6 → EIF2C2 |
| Downstream (Children) |
|---|
| EIF2C2 → LTF (>>) |
| EIF2C2 → NOL4 (>>) |
| EIF2C2 → ENTPD3 (>>) |
| EIF2C2 → LOC647288 (>>) |
| EIF2C2 → PAPPA2 (>>) |
| EIF2C2 → ATAD2 (>>) |
| EIF2C2 → BOP1 (>>) |
| EIF2C2 → PDP1 (>>) |
| EIF2C2 → RIPK2 (>>) |
| EIF2C2 → FZD6 (>>) |
| EIF2C2 → RNMT (>>) |
